Could you tell us about the firm and your role there? Mr. Khuller: I’m the Vice President and Portfolio Manager at Letko Brosseau in Montreal, Canada. We manage about CAD18 billion in assets for our ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...

Can you tell me about the company? Mr. Poirier: Sure. OSE Immunotherapeutics is a French biotech — the company is listed on Euronext Paris — and we are developing immunotherapies. Specifically, these ...

CEO Silviu Itescu explains how Mesoblast changes a disease that is fatal 70% or 90% to a disease that can be cured.

Please give me an overview of the company and its services. Mr. Gonen: MediWound is a global leader in next generation enzymatic therapeutics for tissue repair. Our core active pharmaceutical ...

It’s been a few years since you spoke with The Wall Street Transcript. So, let’s start with a brief overview and history of the company. Dr. Itescu: Sure. So, we’re a mature company. We’re listed on ...

Could you tell me about the company? Mr. Keddie: CompuMed is kind of a unique space. We’re in the telemedicine space. We started out, actually, in the early days, building echocardiogram devices, and ...